Login / Signup

Engineered exoASO-STAT6: a potent monotherapy for oral squamous cell carcinoma.

Vijayashree Priyadharsini JayaseelanArumugam Paramasivam
Published in: Future oncology (London, England) (2022)
Keyphrases
  • combination therapy
  • cell proliferation
  • open label
  • anti inflammatory
  • randomized controlled trial